May
15
2008
May 15: As a precautionary measure against fast spreading bird flu in South East Asia the UK government has began to stockpile anti-viral drug Tamiflu. A recent research has found that stockpiling single drug will not be effective in resisting global flu pandemic.
Tests conducted on the H5N1 strain of bird flu that is rapidly spreading all across South East Asia has found that it is developing resistance to the leading anti-viral drug Tamiflu.
This study was conducted by the Medical Research Council and it emphasised the need for stockpiling more than one kind of drug. The UK government has stockpiled millions of doses of Tamiflu is reviewing its position.
The researchers found that when they passed X-ray crystallography on the key part of flu called neuraminidase (N1), which is responsible for the release of the virus from infected human cells and allows the disease to spread, they characterise a mutation in the structure of N1 that is observed in human cases of H5N1. Due to this mutation the virus become resistant to Tamiflu and remains vulnerable to Relenza.
While commenting on this the lead researcher of the study Dr Steve Gamblin said: “Stockpiling one kind of drug will not provide an effective cover over potential H5N1 pandemic. There is no need to worry as the mutant strains of H5N1 will not spread fast.”
A recent figure has shown that in total 382 people are affected by H5N1 bird flu and 241 of them were killed, the victims were mostly from South East Asia. Most of them who are infected by the disease are poultry workers who have come into intimate contact with infected birds.
Researchers also warn that if the virus acquires the ability to spread from human to human then it will pose huge threat to millions of people all over the world. Health experts in the UK have warned that if such a modified strain emerges then tens of thousands of people could die in Britain alone.
So detailed study and holistic prevention strategy is the need of the hour.

Apr
18
2008
Apr 18: Several researches have revealed the adverse effects of smoking and drinking habits. A US research has exposed the influence of smoking and drinking habits in raising Alzheimer’s risk. According to an estimate in the UK at least 700,000 people are suffering from dementia. The research found that heavy drinkers and chain smokers are more prone to Alzheimer’s, almost six to seven years earlier than those teetotallers and non-smokers.
The findings of the research were presented at the meeting of American Academy of Neurology, it considered 900 people who are over 60 years of age and have the high risk gene. The study gains significance as the delay in inception of Alzheimer’s disease by five years will lead to a 50 per cent drop in the number of cases.
Those who take more than two drinks a day and smoke more than 20 cigarettes a day are more exposed to early onset of Alzheimer’s. People who have specific gene named APOE variant 4 are also likely to get affected by Alzheimer’s. Smoking, drinking and gene variant are the three main factors that beckon Alzheimer’s 8.5 years earlier than the normal case.
According to the lead of the study, Dr Ranjan Duara of Mount Sinai Medical Center in Florida: “To keep Alzheimer’s at bay it is better to quit smoking and drinking, by doing so one can hold-up the risk of Alzheimer’s and can effectively reduce the number of Alzheimer’s cases.”
Another US research found that high cholesterol level in early 40s will also increase the Alzheimer’s risk by one and a half time. This study considered 9,700 men and women and it found that those with high cholesterol level that is over six millimols per litre (mmol/L) are exposed to the risk of Alzheimer’s.
“In spite of diabetes, late-life stroke, high blood pressure and obesity; high mid-life cholesterol will increase the risk of Alzheimer’s a great deal,” said the researcher Alina Solomon.
The ideal way to get rid of the risk posed by Alzheimer’s is by practising healthy diet by including foods that are rich in antioxidants and vitamins and by doing regular exercise.

Feb
29
2008
Feb 29: According to the new statistics released by Global Industry Analysts, Inc. the organ transplant market is expected to reach 115,000 procedures by the year 2012. Most accepted form of organ transplants are heart, kidney, pancreas, liver and lungs. The market is encouraged by the increasing number of adult population and the surge in the number of organ failure due to serious ailments.
The success rate of the organ transplants encouraged by the modern technology also promotes the market of organ transplant. Awareness programmes that are aimed to remove misconception and fear linked with organ donations. Voluntary participation of organ donors who are willing for after-life organ donation has also encouraged the market and it is considered as a social responsibility.
Kidney transplant heads the list of organ transplants and it is expected to reach 78.8 thousand transplants by the year 2012. Liver transplants are expected to reach 1,290 by 2010 in Latin America. Tissue transplantation market that include cornea, skin grafts and heart valves are expected to fetch $5.25 billion by 2012.
The organs like liver and kidney are largely donated by living donors and it has seen a steep rise. The number of stranger donor is higher than those of family donors. Even though the number of organ donation is increasing, demand for organs is far beyond that and it fails to cater the needs of all the patients. One-third of the patients are getting the organs what they are looking for. Finding suitable donor, preventing infections or block in blood vessels are the major hurdles for organ transplantation.
The report is released by Global Industry Analysts, Inc. and it is titled as “Organ and Tissue Transplantation: A Global Strategic Business Report”. The study also includes market data and statistics of transplant procedures in US, Canada, Europe, Japan, Asia, Latin America to name a few.

Feb
26
2008
Feb 26: The traditional medical treatments such as ayurvedic and homeopathic are gaining importance in India as more advertisement and marketing techniques are promoting these medical practices. More and more patients prefer to get traditional treatments to get relief from chronic and lifestyle induced ailments.
While commenting on this Anoop Misra, Department of Diabetes and Metabolism, Fortis Group of Hospitals said: “Ayuveda is the most preferred traditional medical treatment and the demand is rapidly increasing in the last five years to more than 3,000 crores due to the effective marketing of their products supported by scientific proof of its capability to cure some diseases. At the same time these treatments are unable to handle emergency and cardiac treatments.”
According to a survey conducted by The Associated Chambers of Commerce and Industry of India (ASSOCHAM), out of 400 Indian CEOs surveyed as part of this survey, over 40 per cent of the CEOs prefer ayurvedic treatment to minimise stress like naturopathy, massage, acupuncture and acupressure. It also predicted that within 5-6 years the metros and towns will witness many ayurvedic centres that focus on treatment related to stress that is part of the fast paced lifestyle existing in the metros today.
Amrit Kalsi, Senior Medical officer of Delhi Government opined that in the past few years more and more people are choosing homeopathic and ayurvedic treatments instead of allopathic as a remedy to their chronic ailments like respiratory problems, skin diseases, fevers, viral infections, allergic disorders and asthma. This tendency is expected to increase in the coming years.”
This is a clear evidence of the growing appreciation of the traditional ayurvedic and homeopathy medicine in India along with most popular allopathy treatment.
